Firstly, Cyclin D1, a common Wnt target is preferentially expressed in luminal breast cancer, which is inconsistent with other Wnt targets, suggesting that Cyclin D1 amplification may occur in luminal subtype preferentially. This evidence concerns the gene CCND1 and breast carcinoma.